Photo: Depositphotos
Aug 6, 2025, 03:35
Irene Ganan-Gomez: Hematopoietic Stem Cell Hierarchies as Biomarkers of Drug Response in MDS and AML
Irene Ganan-Gomez, Investigatora at Cima University of Navarra, shared a post on LinkedIn she and colleagues co-authored published in Clinical Cancer Research.
“Publication alert!
If you are into myeloid neoplasms, whether it be a physician struggling to pick the best treatment or a translational researcher curious about stem cells, this review is for you! (and everyone else).
Check it out online first at Clinical Cancer Research.”
Title: Hematopoietic Stem Cell Hierarchies as Novel Biomarkers of Drug Response in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Authors: Teresa Ezponda, Ana Aldaz, Ana Alfonso-Pierola, Irene Ganan-Gomez
Read The Full Article at Clinical Cancer Research.
More Posts Featuring Acute Myeloid Leukemia.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 6, 2025, 03:19
Aug 5, 2025, 19:11
Aug 5, 2025, 18:55